Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Elevance Health ( (ELV) ) just unveiled an update.
On February 26, 2026, Elevance Health announced a restructuring of its leadership to simplify decision-making across its Carelon healthcare services arm and Health Benefits businesses. Executive Vice President and CFO Mark Kaye will take on oversight of Carelon, which includes pharmacy, behavioral health, value-based care, and care delivery operations, while Executive Vice President and Chief Health Benefits Officer Felicia Norwood will lead a consolidated Health Benefits organization spanning commercial and government plans.
As part of the shake-up, Carelon president Peter D. Haytaian will step down from his role effective May 4, 2026, for family reasons and remain as a special advisor through December 31, 2026, to support a smooth transition, with the company emphasizing there is no disagreement underlying his departure. Elevance Health simultaneously reaffirmed its full-year 2026 earnings and benefit expense ratio guidance, signaling confidence that the management changes will not disrupt operational performance or its strategy to scale and execute more efficiently for shareholders, clients, and members.
The most recent analyst rating on (ELV) stock is a Hold with a $358.00 price target. To see the full list of analyst forecasts on Elevance Health stock, see the ELV Stock Forecast page.
Spark’s Take on ELV Stock
According to Spark, TipRanks’ AI Analyst, ELV is a Neutral.
ELV’s score is primarily held back by recent margin and cash-flow compression and cautious 2026 guidance that includes membership declines and a negative Medicaid margin. These risks are partially offset by a solid balance sheet, relatively attractive valuation (P/E and dividend), and management’s outlined path to cash-flow improvement and renewed EPS growth beyond 2026.
To see Spark’s full report on ELV stock, click here.
More about Elevance Health
Elevance Health, Inc. is a U.S.-based health benefits and healthcare services company that positions itself as a lifetime, trusted health partner. Through a diverse portfolio of medical, pharmacy, behavioral, clinical, home health, and complex care solutions, its businesses serve roughly 104 million consumers, focusing on lowering the cost of care and improving health outcomes across commercial and government markets.
Average Trading Volume: 1,580,263
Technical Sentiment Signal: Strong Sell
Current Market Cap: $72.2B
See more insights into ELV stock on TipRanks’ Stock Analysis page.